This area focuses on dyslipidemias such as hypercholesterolemia, hypertriglyceridemia, and their roles in atherosclerosis and cardiovascular disease. Hormones such as insulin, cortisol, and thyroid hormones influence lipid metabolism. Treatment includes lifestyle changes, statins, fibrates, and newer agents like PCSK9 inhibitors. Endocrinologists collaborate closely with cardiologists to mitigate risks and enhance cardiovascular results.